All In MedTech

Device Trial Radar · NCT01031004

Vistakon Investigational Lens Worn as a Single Use Daily Wear

Last checked: Nov 20, 2026Latest source record: Jun 19, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

50

Actual

Start

Oct 1, 2009

Primary completion

Dec 1, 2009

Study completion Dec 1, 2009

Sponsor

Lead sponsor
Johnson & Johnson Vision Care, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Dec 14, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is intended to show that the investigational contact lens is clinically equivalent to a currently approved contact lens, when worn as single-use on a daily basis.

Conditions

  • Myopia

Interventions

  • narafilcon BDevice

    contact lens

  • etafilcon ADevice

    contact lens

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Slit Lamp Findings - Corneal EdemaTime frame: after 1 week of lens wear
  2. Corneal Edema at Month 1Time frame: after 1 month of lens wear
  3. Slit Lamp Findings - Corneal NeovascularizationTime frame: after 1 week of lens wear

15 more outcomes with a free account

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Salt Lake City, Utah

  • Site not named

    Virginia Beach, Virginia

  • Site not named

    Laramie, Wyoming

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.